GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vista Pharmaceuticals Ltd (BOM:524711) » Definitions » Market Cap

Vista Pharmaceuticals (BOM:524711) Market Cap : ₹661.07 Mil (As of Mar. 29, 2025)


View and export this data going back to 1994. Start your Free Trial

What is Vista Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Vista Pharmaceuticals's share price for the quarter that ended in Dec. 2024 was ₹11.78. Vista Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 61.55 Mil. Therefore, Vista Pharmaceuticals's market cap for the quarter that ended in Dec. 2024 was ₹725.08 Mil.

Vista Pharmaceuticals's quarterly market cap increased from Jun. 2024 (₹778.63 Mil) to Sep. 2024 (₹815.56 Mil) but then declined from Sep. 2024 (₹815.56 Mil) to Dec. 2024 (₹725.08 Mil).

Vista Pharmaceuticals's annual market cap declined from Mar. 2022 (₹339.24 Mil) to Mar. 2023 (₹313.98 Mil) but then increased from Mar. 2023 (₹313.98 Mil) to Mar. 2024 (₹499.93 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Vista Pharmaceuticals's Enterprise Value for Today is ₹703.18 Mil.


Vista Pharmaceuticals Market Cap Historical Data

The historical data trend for Vista Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vista Pharmaceuticals Market Cap Chart

Vista Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 160.93 332.62 339.24 313.98 499.93

Vista Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 687.99 499.93 778.63 815.56 725.08

Competitive Comparison of Vista Pharmaceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Vista Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vista Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vista Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Vista Pharmaceuticals's Market Cap falls into.


;
;

Vista Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Vista Pharmaceuticals's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹10.66*46.898
=₹499.93

Vista Pharmaceuticals's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=₹11.78*61.552
=₹725.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vista Pharmaceuticals  (BOM:524711) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Vista Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Vista Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Vista Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 104, Kakateeya Hills, Ravindra Co Operative Society, Guttala Begumpet, Hyderabad, TG, IND, 500033
Vista Pharmaceuticals Ltd is an Indian-based company engaged in single operating segment which is the manufacturing of Pharmaceutical products. The company offers over-the-counter and prescription generic drug products such as tablets, capsules, and liquids covering various therapeutic categories. Some of the drugs in tablet dosage forms are Sulfamethoxazole and Trimethoprim, Bismuth Subgallate, Pyrantel Pamoate, Aspirin, Ibuprofen, Ranitidine HCl, and others. Nifedipine, Piroxicam, and Indomethacin are the drugs offered by the company in a capsule dosage form. The company generates all of its operating revenue from sales within India.

Vista Pharmaceuticals Headlines

No Headlines